None
Quote | Anixa Biosciences Inc. (NASDAQ:ANIX)
Last: | $3.22 |
---|---|
Change Percent: | -1.86% |
Open: | $3.28 |
Close: | $3.22 |
High: | $3.44 |
Low: | $3.15 |
Volume: | 114,659 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Anixa Biosciences Inc. (NASDAQ:ANIX)
2024-07-15 08:43:07 ET More on Anixa Biosciences Seeking Alpha’s Quant Rating on Anixa Biosciences Read the full article on Seeking Alpha For further details see: Anixa Biosciences authorizes $5M share buyback program
Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
Message Board Posts | Anixa Biosciences Inc. (NASDAQ:ANIX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ANIX News Article - Anixa Biosciences Announces Presentation on Breast Cancer Vaccine | whytestocks | investorshangout | 03/27/2023 12:35:47 PM |
whytestocks: $ANIX News Article - Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke | whytestocks | investorshangout | 10/31/2022 5:15:49 PM |
whytestocks: $ANIX News Article - Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T T | whytestocks | investorshangout | 10/10/2022 2:15:49 PM |
whytestocks: $ANIX News Article - Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Gl | whytestocks | investorshangout | 08/31/2022 4:20:52 PM |
https://www.google.com/search?q=charlie+maxwell+oil+analyst&ei=UO6mWujgG4nWjwPT- | copytele | investorshub | 03/10/2022 3:51:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Anixa Biosciences Inc. Company Name:
ANIX Stock Symbol:
NASDAQ Market:
Anixa Biosciences Inc. Website:
Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, I...
2024-06-10 07:30:03 ET H.C. Wainwright analyst issues BUY recommendation for ANIX on June 10, 2024 06:07AM ET. The previous analyst recommendation was Buy. ANIX was trading at $2.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...